Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector.

被引：0
|
作者：
Sawai, N
Zhou, S
Vanin, EF
Houghton, PJ
Brent, TP
Sorrentino, BP
机构：
[1] St Jude Childrens Res Hosp, Div Expt Hematol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
904
引用
收藏
页码：212A / 212A
页数：1
相关论文
共 18 条
  • [1] Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector
    Sawai, N
    Zhou, S
    Vanin, EF
    Houghton, P
    Brent, TP
    Sorrentino, BP
    MOLECULAR THERAPY, 2001, 3 (01) : 78 - 87
  • [2] O6-benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells
    Westerhof, GR
    Down, JD
    Blokland, I
    Wood, M
    Boudewijn, A
    Watson, AJ
    McGown, AT
    Ploemacher, RE
    Margison, GP
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (05) : 633 - 638
  • [3] Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide
    Reese, JS
    Davis, BM
    Liu, LL
    Gerson, SL
    CLINICAL CANCER RESEARCH, 1999, 5 (01) : 163 - 169
  • [4] Protection of hematopoietic cells against combined O6-benzylguanine and chloroethylnitrosourea treatment by mutant forms of O6-methylguanine DNA methyltransferase
    DA Williams
    R Maze
    C Kurpad
    A Pegg
    LC Erickson
    Bone Marrow Transplantation, 2000, 25 : S105 - S109
  • [5] Protection of hematopoietic cells against combined O6-benzylguanine and chloroethylnitrosourea treatment by mutant forms of O6-methylguanine DNA methyltransferase
    Williams, DA
    Maze, R
    Kurpad, C
    Pegg, A
    Erickson, LC
    BONE MARROW TRANSPLANTATION, 2000, 25 (Suppl 2) : S105 - S109
  • [6] Efficient in vivo selection of hematopoietic stem cells in a large animal model using MGMT and O6BG/temozolomide
    Neff, T
    Horn, PA
    Williams, DA
    Thomasson, BM
    von Kalle, C
    Peterson, LJ
    Kiem, HP
    MOLECULAR THERAPY, 2003, 7 (05) : S155 - S155
  • [7] Novel mutant alkyltransferase proteins protect hematopoietic cells from O6-benzylguanine (BG) and BCNU and remain active after high dose BG.
    Davis, BM
    Roth, JC
    Liu, LL
    Freibert, SE
    Schupp, JE
    Neumann, A
    Xu-Welliver, M
    Pegg, AE
    Gerson, SL
    BLOOD, 1998, 92 (10) : 466A - 466A
  • [8] MGMT(P140K) Hematopoietic Stem Cell Gene Therapy Enhances Tolerance and Efficacy of Temozolomide in Combination with O6-benzylguanine in Glioblastoma Patients
    Adair, Jennifer E.
    Mrugala, Maciej M.
    Storer, Barry E.
    Johnston, Sandra K.
    Swanson, Kristin R.
    Kiem, Hans-Peter
    MOLECULAR THERAPY, 2014, 22 : S102 - S103
  • [9] Protection of CHO cells by mutant forms of O6-alkylguanine-DNA alkyltransferase from killing by 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine or O6-benzyl-8-oxoguanine
    Loktionova, NA
    Xu-Welliver, M
    Crone, TM
    Kanugula, S
    Pegg, AE
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (02) : 237 - 244
  • [10] Bone marrow repopulation by limited numbers of G156A MGMT transduced hematopoietic cells in non-myeloablated mice after O6-benzylguanine and BCNU mediated selection.
    Davis, BM
    Koc, ON
    Gerson, SL
    BLOOD, 1998, 92 (10) : 691A - 691A
12